Skip to content
TrialScanner

NCT03893487

Fimepinostat in Treating Brain Tumors in Children and Young Adults

Early Phase 1CompletedCRISCollaborator

Registry record

Lead sponsor
Sabine Mueller, MD, PhD
Conditions
Diffuse Intrinsic Pontine Glioma; Recurrent Anaplastic Astrocytoma; Recurrent Glioblastoma; Recurrent Malignant Glioma; Recurrent Medulloblastoma
Primary completion
Oct 31, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03893487 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03893487: Fimepinostat in Treating... | TrialScanner